The global oral proteins and peptides market achieved a valuation of USD 1.8 Billion in 2024 and is projected to expand to USD 3.4 Billion by 2033 at a CAGR of 7.13% from 2025-2033, per IMARC Group. North America, with a dominant 97.8% market share in 2024, is a key growth hub, driven by innovations in drug delivery technologies and a surge in demand for non-invasive treatment options... https://www.imarcgroup.com/oral-proteins-peptides-market